The U.S. Federal Trade Commission (FTC) and four states file a lawsuit against the World Professional Association for Transgender Health (WPATH), a major professional organization focused on transgender healthcare. Multiple outlets report that the FTC alleges WPATH misled parents and doctors about the safety and efficacy of gender-affirming medical treatments for minors. The complaint centers on claims regulators describe as deceptive, including assertions about medical necessity and safety, and that the organization’s guidance helped support youth treatments.
The lawsuit is filed alongside Alaska, Iowa, Nebraska and Texas, according to the reports. Outlets characterize the action as part of a broader effort by the Trump administration and allied policymakers to limit access to gender-affirming care for minors, though the lawsuit itself focuses on alleged consumer-protection and advertising-type deception by WPATH.
All reports indicate that the FTC is bringing the case in federal court and that the dispute concerns statements made by or through the organization’s public-facing guidance and communications. The sources do not describe the outcome, but uniformly present the filing as an attempt to hold WPATH accountable for how it communicated about pediatric gender-affirming care.
